Medpace

Medpace is a full-service contract research organisation (CRO) founded in 1992 and headquartered in Cincinnati, USA. The company advances clinical research through an outsourced, scientifically driven model, supporting the global development of medical therapeutics for clients in biotechnology, pharmaceuticals and medical devices. Its work spans clinical research outsourcing, clinical trial management, clinical operations and regulatory expertise, extending from Phase I studies through later-phase development.

Medpace operates a set of in-house service units that support clinical development programmes. These include central and bioanalytical laboratories, a medical imaging core laboratory for trial assessment, a cardiac safety core laboratory, a dedicated Phase I unit for early-phase studies, and a clinical trial management system (CTMS) used to run trials.

The company has been in operation for more than three decades and maintains personnel, offices and investigator relationships across four major regions: North America, Europe, Latin America and Asia Pacific. Medpace states that it combines local expertise with global resources and positions itself as an extension of clients' teams.

Medpace pursues an organic-growth strategy, avoiding mergers and acquisitions, and places emphasis on team continuity and the avoidance of operational disruption. Its stated focus is on therapeutic, regulatory and operational expertise applied through a scientifically driven approach.